Bellicum Pharma (BLCM) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Join SI Premium – FREE
Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.66), $0.08 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- LiqTech International (LIQT) Reports In-Line Q2 EPS
- Valens Semiconductor (VLN) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
